Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon P L Travis

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Nature Medicine|April 4, 2017
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel diseaseNathaniel R West, Ahmed N Hegazy, Benjamin M J Owens, et al.
Gastroenterology|June 20, 2021
Interferon-Gamma-Producing CD8<sup>+</sup> Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-ColitisSarah C Sasson, Stephanie M Slevin, Vincent T F Cheung, et al.
Transfusion Medicine Reviews|May 28, 2013
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trialVipul Jairath, Brennan C Kahan, Alasdair Gray, et al.
Gastroenterology|November 15, 2021
An Integrated Taxonomy for Monogenic Inflammatory Bowel DiseaseChrissy Bolton, Christopher S Smillie, Sumeet Pandey, et al.
Journal of Gastroenterology and Hepatology|February 18, 2022
Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' ConsortiumRupa Banerjee, Partha Pal, Ida Hilmi, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Nature Medicine|April 4, 2017
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel diseaseNathaniel R West, Ahmed N Hegazy, Benjamin M J Owens, et al.
Gastroenterology|June 20, 2021
Interferon-Gamma-Producing CD8<sup>+</sup> Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-ColitisSarah C Sasson, Stephanie M Slevin, Vincent T F Cheung, et al.
Transfusion Medicine Reviews|May 28, 2013
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trialVipul Jairath, Brennan C Kahan, Alasdair Gray, et al.
Gastroenterology|November 15, 2021
An Integrated Taxonomy for Monogenic Inflammatory Bowel DiseaseChrissy Bolton, Christopher S Smillie, Sumeet Pandey, et al.
Journal of Gastroenterology and Hepatology|February 18, 2022
Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' ConsortiumRupa Banerjee, Partha Pal, Ida Hilmi, et al.
Pageof 9